PRESS RELEASE published on 03/19/2025 at 12:30, 1 year 6 months ago Inside Information / Other news releases Valerio Therapeutics Board of Directors convenes a General Meeting with resolutions on director dismissals, co-optation, share division, bylaws amendment, and formalities powers Board Of Directors General Meeting Resolutions Valerio Therapeutics Share Division
BRIEF published on 02/04/2025 at 10:40, 1 year 8 months ago Valerio Therapeutics opts for strategic refocusing Clinical Trials Oncology Financial Strategy Medical Innovation Valerio Therapeutics
PRESS RELEASE published on 02/04/2025 at 10:35, 1 year 8 months ago Inside Information / Other news releases Valerio Therapeutics refocuses strategy, discontinuing clinical trials for financial reasons. Focus on early-stage drug development Clinical Trials Financial Challenges Valerio Therapeutics Strategy Refocus Early-stage Development
BRIEF published on 10/01/2024 at 00:56, 2 years ago Valerio Therapeutics Reports First Half 2024 Financial Results Financial Results R&D Clinical Trial Valerio Therapeutics Single Domain Antibodies
BRIEF published on 10/01/2024 at 00:45, 2 years ago Valerio Therapeutics Reports Half-Year 2024 Financial Results and Strategic Updates Financial Results Emglev Acquisition VIO-01 Clinical Trial PlatON™ Platform Therapeutic Innovations
PRESS RELEASE published on 10/01/2024 at 00:40, 2 years ago Inside Information: News release on accounts, results Valerio Therapeutics reports its half-year 2024 financial results and updates on its activities, including the acquisition of Emglev Therapeutics and progress on the VIO-01 trial Acquisition Financial Results Valerio Therapeutics VIO-01 Trial Emglev Therapeutics
PRESS RELEASE published on 09/30/2024 at 22:40, 2 years ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report
BRIEF published on 08/05/2024 at 19:23, 2 years 2 months ago Half-yearly review of the liquidity contract with Kepler Cheuvreux Liquidity Contract Transactions Kepler Cheuvreux AMF Valerio Therapeutics
PRESS RELEASE published on 08/05/2024 at 19:18, 2 years 2 months ago Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract Valerio Therapeutics releases half-year liquidity contract statement revealing shares and trading volumes Liquidity Contract Shares AMF Decision Valerio Therapeutics Trading Volumes
BRIEF published on 06/05/2024 at 07:05, 2 years 4 months ago Minutes of the general meeting of Valerio Therapeutics Biotechnology Voting Results General Meeting Resolutions Valerio Therapeutics
Published on 10/08/2026 at 14:31, 3 hours 10 minutes ago First Breach Expands Hiring Initiative to Support Ammunition Production Growth and Planned Drone Manufacturing Operations
Published on 10/08/2026 at 14:30, 3 hours 11 minutes ago Predictiv AI's Shift AI Completes AWS Foundational Technical Review and Expands Aviation Visibility Through AWS Solutions Library
Published on 10/08/2026 at 14:00, 3 hours 41 minutes ago Earthwise Minerals Appoints Andy Randell, P.Geo., to Board of Directors
Published on 10/08/2026 at 14:00, 3 hours 41 minutes ago Orogen Royalties Creates a Royalty on the Cibola Copper-Gold Project in British Columbia
Published on 10/08/2026 at 14:00, 3 hours 41 minutes ago Lobe Sciences Announces Proposed Capital Markets Initiatives to Support Planned Growth
Published on 10/08/2026 at 17:30, 11 minutes ago EQS-Adhoc: Shelly Group Reports Preliminary Consolidated Revenue for the First Nine Months of 2026
Published on 10/08/2026 at 16:40, 1 hour ago Klöckner & Co sells Becker Group to consortium of Accura and BCB
Published on 10/08/2026 at 16:05, 1 hour 36 minutes ago Duck Creek Technologies Expands Leadership to Accelerate Underwriting Innovation and EMEA Growth
Published on 10/08/2026 at 15:07, 2 hours 34 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 10/08/2026 at 15:06, 2 hours 35 minutes ago Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 10/07/2026 at 18:19, 23 hours 21 minutes ago Outstanding shares and voting rights statement at 30 September 2026
Published on 10/07/2026 at 17:45, 23 hours 56 minutes ago Availability of the Pre-Q3 2026 Sales Communication
Published on 10/07/2026 at 15:54, 1 day 1 hour ago Disclosure of Share Capital and Voting Rights as of September 30, 2026
Published on 10/07/2026 at 08:15, 1 day 9 hours ago EURAZEO TO ACQUIRE MIYA WATER, A GLOBAL SPECIALIST IN EFFICIENT WATER MANAGEMENT SOLUTIONS
